
IDEX (IEX) Stock Forecast & Price Target
IDEX (IEX) Analyst Ratings
Bulls say
IDEX is poised for growth with core sales projected to increase by 1.5%-2% in 2026, supported by a robust 7% increase in orders driven by strong demand in key sectors such as data centers and municipal water. The company's organic revenue growth of 5% in 2025 exceeded previous estimates, particularly boosted by performance in the Fluid and Metering Technologies (FMT) and Health and Science Technologies (HST) segments, even amidst challenges in the Asia/European markets. Additionally, IDEX's management anticipates that recent portfolio management initiatives may enhance the base growth rate, further solidifying a positive outlook as earnings potential in niche markets like space, defense, and pharmaceuticals appears promising.
Bears say
IDEX's financial outlook appears negative due to mixed organic sales and order trends across its segments, leading to a reduction in core revenue growth forecasts for 2026, with expectations of flat volume countered by price capture. The company’s gross debt/EBITDA ratio stands at 2.0x, and although net debt/EBITDA has improved to 1.3x, the balance sheet remains susceptible to economic fluctuations, particularly given its exposure to cyclical markets. In a downside scenario, IDEX may face prolonged organic revenue declines and operating margin pressures, which could reduce cash earnings per share to approximately $7.61 in 2026, indicating significant operational risks ahead.
This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.
IDEX (IEX) Analyst Forecast & Price Prediction
Start investing in IDEX (IEX)
Order type
Buy in
Order amount
Est. shares
0 shares